[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"National Institute of Hygiene and Epidemiology, Vietnam\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":56},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":33,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":44,"lastUpdatePostDateStruct":45,"startDateStruct":48,"completionDateStruct":50,"leadSponsor":52,"locationsCount":55},"100568469","phase-2-effector-and-memory-immune-responses-to-hpv-vaccination-in-vietnamese-women-post-virus-exposure-100568469",false,"NCT06681636","Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure","A Non-inferiority Study Comparing the Immunogenicity of a Standard or an Extended Three-dose Nonavalent Human Papillomavirus Vaccine Schedule Between High-risk Women Aged 18-26 Years and Age-matched Women in the General Population","HPV9vxFSW","Inclusion Criteria:\n\n* Is between the reporting ages of 18-26 years at the time of recruitment.\n* Engage in commercial sex in the last 6m (for FSW group) or have engaged in sexual activity (non-FSWs)\n* Willing and able to give written informed consent.\n* Willing to complete the follow-up requirements of the study.\n\nExclusion criteria\n\nParticipants meeting any of the following criteria will be excluded from the trial:\n\n* Pregnant or possibly pregnant\n* Has received any HPV vaccine previously\n* Has an axillary temperate greater than 38°C\n* Known allergies to any vaccine component\n* incapacity to provide consent\n* Currently receiving immunosuppressive medication or anti-cancer chemotherapy.\n* Known HIV infection.\n* Known Congenital immune deficiency syndrome.",true,"FEMALE","18 Years","26 Years",{"count":22,"type":23},300,"ESTIMATED","INTERVENTIONAL",[26],"PHASE2","A Study to evaluate if the 3 dose extended schedule (0-6-18 months) for the HPV vaccine Gardasil-9 provide similar immune responses and short term protection against HPV infection compared to the regular 3 dose schedule (0-2-6 months) in high risk women in Vietnam",[29,30,31,32],"HPV Infection","Cervical Cancer","Anogenital Cancer","Anogenital Warts",[34,35,36,37,38,39,40,41,42],"human papillomavirus","HPV vaccine","Vietnam","Female sex workers","immunogenicity","protection","extended schedule","HPV infection","cervical cancer","NOT_YET_RECRUITING","2024-11-07",{"date":46,"type":47},"2024-11-08","ACTUAL",{"date":49,"type":23},"2024-12-14",{"date":51,"type":23},"2027-12-31",{"name":53,"class":54},"National Institute of Hygiene and Epidemiology, Vietnam","OTHER",3,""]